This paper investigates the relationship between university alliances and firm exploratory innovation in the context of therapeutic product development. We build on organizational learning theory to elucidate that the use of university alliances is more positively associated with firm exploratory rather than exploitative innovation output. Moreover, we argue that the breadth of a firm's technological expertise strengthens the benefits of university alliances in the development of exploratory innovation output. Our empirical analysis is based on a panel dataset of 220 US therapeutic biotechnology firms from 2003 to 2010. Our findings support the contention that university alliances are differentially related to exploratory and exploitative innovation outcomes, and further indicate that firm technological breadth positively moderates the relationship between university alliances and firm exploratory innovation.

本文研究了治疗产品开发背景下的大学联盟与企业探索性创新之间的关系。我们以组织学习理论为基础，阐明大学联盟的使用与企业探索而不是剥削性创新产出更正相关。此外，我们认为，企业技术专长的广度可增强大学联盟在探索性创新产品开发中的收益。我们的经验分析基于2003年至2010年间220家美国治疗性生物技术公司的面板数据集。我们的发现支持以下论点：大学联盟与探索性和开发性创新成果有不同的相关性，